Vigil Neuroscience Inc Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
0M
-
0M
0M
88M
28M
61M
-89M
0M
-83M
0M
-83M
22.02%
89M
5M
-88M
0M
-89M
0M
-
1M
-1M
69M
21M
47M
-69M
0M
-68M
0M
-68M
56.58%
69M
1M
-69M
0M
-69M
0M
-
0M
0M
42M
10M
32M
-42M
43M
-43M
0M
-43M
51.52%
42M
0M
-42M
0M
-42M
0M
-
0M
0M
6M
0M
5M
-6M
0M
-29M
0M
-29M
51.52%
6M
0M
-6M
0M
-6M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
4Q2020
3Q2020
0M
-
0M
0M
24M
7M
17M
-24M
0M
-22M
0M
-22M
-254.68%
24M
2M
-24M
0M
-24M
0M
-
0M
0M
22M
7M
15M
-22M
0M
-20M
0M
-20M
18.04%
22M
2M
-22M
0M
-22M
0M
-
0M
0M
22M
7M
15M
-22M
0M
-20M
0M
-20M
18.75%
22M
2M
-22M
0M
-22M
0M
-
0M
0M
21M
7M
14M
-21M
1M
-20M
0M
-19M
22.26%
21M
1M
-21M
0M
-21M
0M
-
0M
0M
19M
7M
12M
-19M
0M
-18M
0M
14M
-210.40%
19M
0M
-19M
0M
-19M
0M
-
0M
0M
18M
5M
13M
-18M
0M
-18M
0M
-17M
61.67%
18M
0M
-18M
0M
-18M
0M
-
0M
0M
17M
5M
12M
-17M
0M
-17M
0M
-17M
49.45%
17M
0M
-17M
0M
-17M
0M
-
0M
0M
15M
5M
10M
-15M
0M
-15M
0M
-15M
87.23%
15M
0M
-15M
0M
-15M
0M
-
0M
0M
13M
4M
9M
-13M
13M
-13M
0M
-13M
206.54%
13M
0M
-13M
0M
-13M
0M
-
0M
0M
11M
3M
8M
-11M
0M
-11M
0M
-11M
-55.82%
11M
0M
-11M
0M
-11M
0M
-
0M
0M
11M
2M
9M
-11M
0M
-11M
0M
-11M
-55.82%
11M
0M
-11M
0M
-11M
0M
-
0M
0M
8M
1M
7M
-8M
0M
-8M
0M
-8M
-55.82%
8M
0M
-8M
0M
-8M
0M
-
0M
0M
4M
1M
3M
-4M
0M
-4M
0M
-4M
-55.82%
4M
0M
-4M
0M
0M
0M
-
0M
0M
23M
1M
22M
-23M
0M
-24M
0M
-24M
-55.82%
23M
0M
-23M
0M
-2M